Baxalta (BXLT) Tops Q3 EPS by 7c; Updates FY15 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. META
6. INTC
7. JBLU
8. ANT
9. NVDA
10. AAPL

Go back to Baxalta (BXLT) Tops Q3 EPS by 7c; Updates FY15 EPS Outlook

Baxalta Announces Strong Sales and Earnings for Third Quarter Exceeding Guidance, Raises Second Half 2015 Outlook

October 29, 2015 6:41 AM EDT

Higher global demand bolsters growth for companys leading hematology and immunology therapies Successfully integrating ONCASPAR acquisition into new oncology business Key milestone achievements advance pipeline toward delivering 20 new product launches by 2020 Preliminary 2016 guidance reflects positive sales momentum, strong operational performance, and Adjusted EPS of $2.15 to $2.25 per diluted share (GAAP EPS of $2.07 to $2.17 per diluted share)

BANNOCKBURN, Ill.--(BUSINESS WIRE)-- Baxalta Incorporated (NYSE: BXLT) today reported strong third quarter financial results, exceeding its... More